Search
  1. Home
  2. Africa

Brazil to make cheap drugs in Africa

    JOHANNESBURG

    Brazil is set to build three plants in Africa for the manufacturing of cheap HIV/AIDS drugs, Reuters reported on Monday.

    The African Union (AU) recently announced an agreement with Brazil to offer a lifeline to millions of people living with HIV/AIDS in the world's poorest continent.

    Having kept HIV infections to less than one percent of its population, Brazil has been hailed as a pioneer in making generic versions of HIV/AIDS drugs.

    "Millions of people are dying and unless we tackle this problem, development will be hindered. We need billions of dollars at the moment for HIV/AIDS drugs and many countries cannot afford the kind of money needed for the drugs," AU interim chairman, Amara Essy, said in a statement.

    Essy did not say when the projects would get underway, but added the AU and Brazil would meet in April to discuss the plans.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join